tiprankstipranks
Trending News
More News >

Panbela Therapeutics downgraded to Neutral from Buy at H.C. Wainwright

H.C. Wainwright downgraded Panbela Therapeutics to Neutral from Buy and removed the firm’s price target after the company announced Q1 results and offered a corporate update. Panbela is considering implementing a reverse stock split in the near future as it intends to pursue a listing on the U.S. Equity Listings Tier II of the Chicago Board Options Exchange, or CBOE. If successful, Panbela plans to conduct an offering to raise additional capital, notes the firm, which notes that these moves would result in further dilution.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue